Anti-human immunodeficiency virus activities of nucleosides and nucleotides: Correlation with molecular electrostatic potential data

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 11, 2000, Pages 2939-2947

  Mickle, T ^a   Nair, V ^a  

^a E11 SSH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; ANTIVIRUS AGENT; CARBOVIR; LAMIVUDINE; NUCLEOSIDE TRIPHOSPHATE; NUCLEOTIDE DERIVATIVE; OXETANOCIN A; RNA DIRECTED DNA POLYMERASE; ZALCITABINE; ZIDOVUDINE; ZIDOVUDINE 5' TRIPHOSPHATE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG CONFORMATION; ELECTRIC POTENTIAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROGEN BOND; MOLECULAR MODEL; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANTI-HIV AGENTS; CELLS, CULTURED; ELECTRON SPIN RESONANCE SPECTROSCOPY; ELECTROSTATICS; HIV; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NUCLEOSIDES; NUCLEOTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033744184     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.11.2939-2947.2000     Document Type: Article

References (39)

1. Conformational analysis of the sugar ring in nucleosides and nucleotides. A new description using the concept of pseudorotation
2. Molecular electrostatic potential analysis for enzymatic substrates, competitive inhibitors, and transition-state inhibitors
3. Anti-retrovirus activity of 3'-fluoro and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues
4. Solution conformation of the anti-HIV active compound (S,S)-isodideoxyadenosine
5. Anti-human immunodeficiency and anti-hepatitis B virus activities of beta-L-2',3'-dideoxypurine nucleosides
6. Structure-activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type I in peripheral mononuclear cells
7. Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells
8. AZT and related compounds - A theoretical study
9. The separated enantiomers of 2'-deoxy-3' thiacytidine (BCH189) both inhibit HIV replication in vitro
10. Anti-human immunodeficiency virus activities of the β-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro
11. Synthesis and anti-HIV activity of different sugar modified pyrimidine and purine nucleosides
12. 3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents
13. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance
14. Synthesis and anti-HIV activity of isonucleosides
15. Enantiospecific synthesis of 3'-hetero-dideoxynucleoside analogues as potential anti-HIV agents
16. Potential anti-AIDS drugs, 2',3'-dideoxycytidine analogues
17. 1,3-Dioxolanylpurine nucleosides (2R,4R) and (2R,4S) with selective anti-HIV-1 activity in human lymphocytes
18. L-β-(2S,4S)- and L-α-(2S,4S)-dioxolanyl nucleosides as potential anti-HIV agents: Asymmetric synthesis and structure-activity relationships
19. Nonlinear dependence in comparative molecular field analysis (CoMFA)
20. Direct prediction of dissociation constants (pKa's) of clondine-like imidazolines, 2-substituted imidazoles and 1-methyl-2-substituted imidazoles from 3D structures using a comparative molecular field analysis (CoMFA) approach
21. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complex with an inhibitor
22. Synthesis and anti-viral activity of various 3'-azido analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1, HTLV-III/LAV)
23. Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-β-L-cytidine (β-L-D4C) and 2',3'-dideoxy-2',3'-didehydro-β-L-5-fluorocytidine (β-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human immunodeficiency virus (HIV) in vitro
24. Anti-human immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2-deoxy-3-oxa-4-thiocytidine and their 5-fluoro analogs in vitro
25. HIV-1 reverse transcriptase can discriminate between two conformationally locked carbocyclic AZT triphosphate analogues
26. Synthesis and antiviral activity of monofluoro and difluoro analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1)
27. Correlation of anti-HIV activities with structure: Use of electrostatic potential and conformational analysis
28. Structure-activity relationship for some 2',3'-dideoxynucleoside anti-HIV drugs using molecular electrostatic potential mapping
29. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides
30. Antiviral activities of isomeric dideoxy-nucleosides of D- and L-related stereochemistry
31. Antiviral, metabolic and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl) tetrahydro-2(S)-furanomethanol
32. Review of HIV-1 reverse transcriptase three-dimensional structure: Implications for drug design
33. Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides
34. Inhibition of infectivity of HIV by a novel nucleoside, oxetanocin, and related compounds
35. Synthesis and anti-HIV evaluation of 2',3'-dideoxyribo-5-chloro-pyrimidine analogues: Reduced toxicity of 5-chlorinated 2',3'-dideoxynucleosides
36. Correlation between preferred sugar ring conformation and activity of nucleoside analogues against human immunodeficiency virus
37. Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virus in vitro